Cryptozoology

Paul McCarthy's story about cryptozoologists (The Scientist, Jan. 11, 1993, page 1) left me wondering why these researchers are so scorned by other scientists and by funding agencies when evolutionary biologists engage in the same activity. McCarthy noted that French zoologist Bernard Heuvelmans coined the term "cryptozoology" to describe the study of unverified animals. Of course, that's what evolutionists do when they speculate about undiscovered transitional fauna in the fossil record. Rec

Written byMims Iii
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Paul McCarthy's story about cryptozoologists (The Scientist, Jan. 11, 1993, page 1) left me wondering why these researchers are so scorned by other scientists and by funding agencies when evolutionary biologists engage in the same activity.

McCarthy noted that French zoologist Bernard Heuvelmans coined the term "cryptozoology" to describe the study of unverified animals. Of course, that's what evolutionists do when they speculate about undiscovered transitional fauna in the fossil record. Recently it has become fashionable to ascribe the absence of transitional forms to the sudden development of new species. Yet in The Origin of Species, Charles Darwin sharply criticized speculation that species could suddenly arise, thereby leaving no fossil trail. Those who claim God had a hand in any of this are ridiculed even more than the cryptozoologists.

With as many as 10 million undiscovered insect species alone, science needs fewer cryptozoologists and more traditional naturalists. The ongoing destruction ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies